Rival Companies to Work Together in COVID Fight

March 2, 2021 by TWN Staff
White House press secretary Jen Psaki speaks during a press briefing at the White House, Tuesday, March 2, 2021, in Washington. (AP Photo/Evan Vucci)

Pharmceutical giant Merck & Co. will help produce rival Johnson & Johnson’s newly approved coronavirus vaccine in an effort to expand supply more quickly, the White House announcedTuesday.

The partnership will help advance the administration’s goal of speeding up production of the single-dose vaccine and accelerate the nation’s plans to vaccinate nearly all adult Americans in the coming months.

The government will facilitate this partnership in several key ways, including invoking the Defense Production Act to equip two Merck facilities to the standards necessary to safely manufacture the vaccine, and asking the Department of Defense to provide daily logistical support to strengthen Johnson & Johnson’s efforts.

White House press secretary Jen Psaki also announced Tuesday that the federal government was increasing supply of the Moderna and Pfizer vaccines to states next week to 15.2 million doses per week, up from 14.5 million previously. In addition, states will receive 2.8 million doses of the newly approved Johnson & Johnson vaccine, Psaki said.

“So they are receiving a total of 18 million doses,” said Psaki.

All those developments enabled President Biden to announce Tuesday afternoon that the United States will have enough vaccine supply to vaccinate all American adults for coronavirus by the end of May, crediting a “stepped up process” under his administration.

“We’re now on track to have enough vaccine supply for every adult in America by the end of May,” Biden said in remarks at the White House. “When we came into office the prior administration had contracted for not nearly enough vaccine to cover adults in America. We rectified that.”

In addition, the AP reports that on n a call with governors Tuesday, White House coronavirus coordinator Jeff Zients said states should prepare for administering 16-17 million total weekly doses of Pfizer and Moderna vaccines by the end of March, climbing to 17-18 million weekly by early April.

The supply of J&J doses to states is expected to climb to 4-6 million weekly doses by the end of March and 5-6 million doses weekly through the end of April.

More than 800,000 doses of the J&J vaccine will also be distributed this week to pharmacies to administer in a separate federally-run program that also includes 2.4 million doses of the other two shots. Both figures are expected to steadily increase, as the White House increasingly looks to the capacity of pharmacy chains like CVS and Walgreens to help speed the nation’s mass vaccination campaign.

In The News

Health

Voting

Health

Biden Says Pause on J&J Shots Shows Gov't Putting Safety 1st
Health
Biden Says Pause on J&J Shots Shows Gov't Putting Safety 1st

WASHINGTON (AP) — President Joe Biden's COVID-19 vaccination campaign hit a snag when federal regulators recommended a "pause" in administering Johnson & Johnson shots. But the White House portrayed the action as important validation of his measured approach throughout the rollout. Biden declared Tuesday that even... Read More

Spoleto Festival USA Resuming In Charleson
Arts
Spoleto Festival USA Resuming In Charleson
April 13, 2021
by Dan McCue

CHARLESTON, S.C. - Charleston, S.C., is known for many things.  Southern charm.  Restaurants. Idyllic, Sun-soaked days. Being home to one of the nation’s busiest and most successful ports. But perhaps nothing brings more visitors to the city and the surrounding Lowcountry than the annual Spoleto Festival... Read More

US Recommends 'Pause' for J&J Vaccine Over Clot Reports
Health
US Recommends 'Pause' for J&J Vaccine Over Clot Reports

WASHINGTON (AP) — The U.S. is recommending a "pause" in administration of the single-dose Johnson & Johnson COVID-19 vaccine to investigate reports of potentially dangerous blood clots.In a joint statement Tuesday, the Centers for Disease Control and Prevention and the Food and Drug Administration said they... Read More

Enhanced Risk of PTSD for Frontline Health Workers
Mental Health
Enhanced Risk of PTSD for Frontline Health Workers
April 13, 2021
by Alexa Hornbeck

A new study, led by University of Utah Health scientists, suggests that more than half of doctors, nurses, and emergency responders involved in COVID-19 care could be at risk for one or more mental health problems, including acute traumatic stress, depression, anxiety, problematic alcohol use, and... Read More

More Research Needed on Impact of COVID-19 on HIV
Health
More Research Needed on Impact of COVID-19 on HIV
April 9, 2021
by Alexa Hornbeck

BETHESDA, Md. - The National Institutes of Health released a call for research on how COVID-19 may be indirectly and directly impacting those with HIV. According to the written statement the, “COVID-19 pandemic is affecting people with or at risk for HIV by interfering with HIV... Read More

Individuals with Disabilities at High Risk of Sexual Assault
Sexual Assault
Individuals with Disabilities at High Risk of Sexual Assault
April 9, 2021
by Alexa Hornbeck

The Bureau of Justice Statistics issued a report stating those with intellectual disabilities are sexually assaulted at a rate seven times higher than those without disabilities.  “Persons with developmental disabilities are at highest risk of sexual assault in this country,” said Nora Baladerian, the founder and... Read More

News From The Well
scroll top